Improvement of Thermal Processes for Using Residues from Bioethanol and Sugar Production in Brazil: Experiments and Proposed Optimization Measures

Within a national funded Brazilian-German cooperation project ASHES, the thermal utilization of bagasse and other residuals from the sugar processing industry was examined. The characterization of the ashes was also performed but it is not in the focus of this paper. To determine the relevant combustion parameters, tests were carried out in a laboratory-scale, fixed bed reactor (KLEAA) at KIT-ITC. Subsequently, Fraunhofer UMSICHT carried out tests in continuously operated combustion plants with different plant sizes of 30 kW, 100 kW, and 440 kW. All relevant compositions were analyzed by CUTEC. The primary objective was to gain knowledge regarding the combustion and emission behavior of the fuels. These findings were used to identify optimization potentials at various points and elaborate concepts for their improvement. In the next steps of the project, optimization of these concepts will be the focus. In cooperation with the Brazilian project partners, several of them should be implemented into practice after the project

Clinically applicable CD34(+)-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

Allogeneic stem cell transplantation (alloSCT), following induction chemotherapy, can be curative for hemato-oncology patients due to powerful graft-versus-tumor immunity. However, disease recurrence remains the major cause of treatment failure, emphasizing the need for potent adjuvant immunotherapy. In this regard, dendritic cell (DC) vaccination is highly attractive, as DCs are the key orchestrators of innate and adaptive immunity. Natural DC subsets are postulated to be more powerful compared with monocyte-derived DCs, due to their unique functional properties and cross-talk capacity. Yet, obtaining sufficient numbers of natural DCs, particularly type 1 conventional DCs (cDC1s), is challenging due to low frequencies in human blood. We developed a clinically applicable culture protocol using donor-derived G-CSF mobilized CD34(+) hematopoietic progenitor cells (HPCs) for simultaneous generation of high numbers of cDC1s, cDC2s and plasmacytoid DCs (pDCs). Transcriptomic analyses demonstrated that these ex vivo-generated DCs highly resemble their in vivo blood counterparts. In more detail, we demonstrated that the CD141(+)CLEG9A(+) cDC1 subset exhibited key features of in vivo cDC1s, reflected by high expression of co-stimulatory molecules and release of IL-12p70 and TNF-alpha. Furthermore, cDC1s efficiently primed alloreactive T cells, potently cross-presented long-peptides and boosted expansion of minor histocompatibility antigen-experienced T cells. Moreover, they strongly enhanced NK cell activation, degranulation and anti-leukemic reactivity. Together, we developed a robust culture protocol to generate highly functional blood DC subsets for in vivo application as tailored adjuvant immunotherapy to boost innate and adaptive anti-tumor immunity in alloSCT patients.Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease

Improvement of Thermal Processes for Using Residues from Bioethanol and Sugar Production in Brazil: Experiments and Proposed Optimization Measures

Within a national funded Brazilian-German cooperation project ASHES, the thermal utilization of bagasse and other residuals from the sugar processing industry was examined. The characterization of the ashes was also performed but it is not in the focus of this paper. To determine the relevant combustion parameters, tests were carried out in a laboratory-scale, fixed bed reactor (KLEAA) at KIT-ITC. Subsequently, Fraunhofer UMSICHT carried out tests in continuously operated combustion plants with different plant sizes of 30 kW, 100 kW, and 440 kW. All relevant compositions were analyzed by CUTEC. The primary objective was to gain knowledge regarding the combustion and emission behavior of the fuels. These findings were used to identify optimization potentials at various points and elaborate concepts for their improvement. In the next steps of the project, optimization of these concepts will be the focus. In cooperation with the Brazilian project partners, several of them should be implemented into practice after the project

Vergleich von thermischen Verfahren zur Nutzung von Rückständen aus der Bioethanolerzeugung und Zuckerherstellung in Brasilien

Within the BMBF-funded Brazilian-German cooperation project ASHES, the thermal utilization of bagasse and other residuals from the sugar processing industry was examined. In the laboratory scale, tests were carried out on the KLEAA system of the KIT-ITC to determine relevant fuel parameters. Subsequently, Fraunhofer UMSICHT carried out tests on combustion plants on a technical scale with different plant sizes of 30 kW, 100 kW and 440 kW. The primary objective was to gain knowledge regardimg the combustion and emission behavior of these fuels. Experiments were also carried out at the CUTEC's ArtFuel facility, a gasification unit in the pilot plant scale, and thus gained information regarding the gasification behavior of bagasse and other residuals from sugar cane processing industry. These findings were used to identify optimization potentials at various points and elaborate concepts for their improvement. Within in the next steps of the project future development of these concepts will be focused. In cooperation with the Brazilian project partners several of these concepts should be implemented into practice after the project

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells

Summary: Umbilical cord blood (UCB) CD34+ progenitor cell-derived natural killer (NK) cells exert efficient cytotoxicity against various melanoma cell lines. Of interest, the relative cytotoxic performance of individual UCB donors was consistent throughout the melanoma panel and correlated with IFNγ, TNF, perforin and granzyme B levels. Importantly, intrinsic perforin and Granzyme B load predicts NK cell cytotoxic capacity. Exploring the mode of action revealed involvement of the activating receptors NKG2D, DNAM-1, NKp30, NKp44, NKp46 and most importantly of TRAIL. Strikingly, combinatorial receptor blocking led to more pronounced inhibition of cytotoxicity (up to 95%) than individual receptor blocking, especially in combination with TRAIL-blocking, suggesting synergistic cytotoxic NK cell activity via engagement of multiple receptors which was also confirmed in a spheroid model. Importantly, lack of NK cell-related gene signature in metastatic melanomas correlates with poor survival highlighting the clinical significance of NK cell therapies as a promising treatment for high-risk melanoma patients